Innovation in Central and Eastern Europe: An Editorial
-
Peter Robbins
This special issue explores an interdisciplinary topic that lies at the heart of Studies in Ethics, Law, and Technology. The life science industry is increasingly recognised as a key sector in the growth and development of many economies. As it gains momentum, policymakers are confronted with the need to facilitate growth whilst dealing with important ethical and regulatory challenges arising from new technosciences addressing human health and the environment. Such activities present special opportunities and threats to emerging economies such as those in Central and Eastern Europe (CEE). Countries transitioning from state-run to free market economies are confronted with the need to engage with new actors within the innovation system, such as transnational corporations and public-private partnerships while finding a place within processes of scientific and academic globalisation. At the same time science throws up new social and ethical dilemmas connected with issues such as genetic databases, drug trials and GM crops. The special issue emerged from a workshop held in Prague in October 2007 that attempted to map a number of these dynamics within the region, and explore cases from outside of it that might inform life sciences development.
©2011 Walter de Gruyter GmbH & Co. KG, Berlin/Boston
Artikel in diesem Heft
- Editorial Essay
- Life Sciences Innovation in Central and Eastern Europe: Conceptual Frameworks and Contributions
- Article
- Go East? Multinational Companies in the Czech Life Sciences
- Innovative Potential in Hungarian Agricultural Biotechnology and the Evolution of Networks
- The Rise and Fall of the Estonian Genome Project
- Alternative IP Mechanisms in Genomic Research
- Biopharmaceutical Innovation Capacities - Benchmarking Europe and Implications for CEE
- Editorial
- Innovation in Central and Eastern Europe: An Editorial
Artikel in diesem Heft
- Editorial Essay
- Life Sciences Innovation in Central and Eastern Europe: Conceptual Frameworks and Contributions
- Article
- Go East? Multinational Companies in the Czech Life Sciences
- Innovative Potential in Hungarian Agricultural Biotechnology and the Evolution of Networks
- The Rise and Fall of the Estonian Genome Project
- Alternative IP Mechanisms in Genomic Research
- Biopharmaceutical Innovation Capacities - Benchmarking Europe and Implications for CEE
- Editorial
- Innovation in Central and Eastern Europe: An Editorial
